bioRxiv Science⌕ Search

Biology subjects

Keukeleire, P.

Publications and source records attributed to Keukeleire, P..

3 recordsLinked to original sources

Uniform processing and analysis of IGVF massively parallel reporter assay data with MPRAsnakeflow

As researchers and clinicians seek to identify human genomic alterations relevant to traits and disorders, identifying and aggregating evidence providing mechanistic support for associations between alterations and phenotypes remains challenging. In particular, the study of non-coding genomic variation remains a major challenge due to the lack of accurate functional annotation for activity in a given context and across alleles. Experimental evidence is critical for prioritizing and interpreting functional effects of genetic alterations. Massively Parallel Reporter Assays (MPRAs) have emerged as a powerful high-throughput approach, enabling quantification of regulatory element activity and allelic effects, and systematic dissection of gene regulatory logic and variant effects across different contexts. However, the diversity of MPRA designs, lack of standardized formats, and many potential processing parameters hamper data integration, reproducibility, and meta-analyses across studies. To address these challenges, the Impact of Genomic Variation on Function (IGVF) Consortium established an MPRA focus group to develop community standards, including harmonized file formats, and robust analysis pipelines for a wide range of library types and experimental designs. Here, we present these formats and comprehensive computational tools, MPRAlib and MPRAsnakeflow, for uniform processing from raw sequencing reads to counts, processing and visualization. Using diverse MPRA datasets, we characterize technical variability sources including barcode sequence bias, outlier barcodes, and delivery method (episomal vs. lentiviral). Our results establish best practices for MPRA data generation and analysis, facilitating robust, reproducible research and large-scale integration. The presented tools and standards are publicly available, providing a foundation for future collaborative efforts in regulatory genomics.

genomics↗

Capture-C MPRA: A high-throughput method to simultaneously characterize promoter interactions and regulatory activity

Cis regulatory elements (CREs) interact with their target promoters over long genomic distances and can be identified using chromatin conformation capture (3C) assays. Their regulatory activity can be functionally characterized in a high-throughput manner using massively parallel reporter assays (MPRAs) that generally test an enhancer alongside a minimal promoter. Here, we developed a novel technology called Capture-C MPRA (ccMPRA) that combines both technologies and can simultaneously obtain chromatin interactions and measure CRE activity alongside their target promoters. We utilized ccMPRA to analyze the regulatory activity of 650 promoters interacting with 42,719 sequences. As C-based techniques also capture isolated promoters, we were able to obtain promoter baseline activity, enabling the identification of both enhancers and silencers. Analysis of CREs interacting with more than one promoter showed significant activity differences depending on the promoter. In summary, ccMPRA can simultaneously characterize chromatin interactions and regulatory activity, allowing to further dissect regulatory grammar.

genomics↗

Cell type deconvolution of methylated cell-free DNA atthe resolution of individual reads

Cell-free DNA (cfDNA) are DNA fragments originating from dying cells that are detectable in bodily fluids, such as the plasma. Accelerated cell death, for example caused by disease, induces an elevated concentration of cfDNA. As a result, determining the cell type origins of cfDNA molecules can provide information about an individuals health. In this work, we aim to increase the sensitivity of methylation-based cell type deconvolution by adapting an existing method, CelFiE, which uses the methylation beta values of individual CpG sites to estimate cell type proportions. Our new method, CelFEER, instead differentiates cell types by the average methylation values within individual reads. We additionally improved the originally reported performance of CelFiE by using a new approach for finding marker regions that are differentially methylated between cell types. This approach compares the methylation values over 500 bp regions instead of at single CpG sites and solely takes hypomethylated regions into account. We show that CelFEER estimates cell type proportions with a higher correlation (r2 = 0.94{+/-}0.04) than CelFiE (r2 = 0.86{+/-} 0.09) on simulated mixtures of cell types. Moreover, we found that it can find a significant difference between the skeletal muscle cfDNA fraction in four ALS patients and four healthy controls.

bioinformatics↗